Product NDC: | 29336-540 |
Proprietary Name: | Norflex |
Non Proprietary Name: | orphenadrine citrate |
Active Ingredient(s): | 60 mg/2mL & nbsp; orphenadrine citrate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 29336-540 |
Labeler Name: | Graceway Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA013055 |
Marketing Category: | NDA |
Start Marketing Date: | 20100525 |
Package NDC: | 29336-540-06 |
Package Description: | 6 AMPULE in 1 BOX (29336-540-06) > 2 mL in 1 AMPULE |
NDC Code | 29336-540-06 |
Proprietary Name | Norflex |
Package Description | 6 AMPULE in 1 BOX (29336-540-06) > 2 mL in 1 AMPULE |
Product NDC | 29336-540 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | orphenadrine citrate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20100525 |
Marketing Category Name | NDA |
Labeler Name | Graceway Pharmaceuticals, LLC |
Substance Name | ORPHENADRINE CITRATE |
Strength Number | 60 |
Strength Unit | mg/2mL |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |